Levofloxacin plus Metronidazole Administered Once Daily versus Moxifloxacin Monotherapy against a Mixed Infection of Escherichia coli and Bacteroides fragilis in an In Vitro Pharmacodynamic Model

Moxifloxacin has been suggested as an option for monotherapy of intra-abdominal infections. Recent data support the use of a once-daily metronidazole regimen. The purpose of this study was to investigate the activity of levofloxacin (750 mg every 24 h [q24h]) plus metronidazole (1,500 mg q24h) compa...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Hermsen, Elizabeth D., Hovde, Laurie B., Sprandel, Kelly A., Rodvold, Keith A., Rotschafer, John C.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2005
Schlagworte:	Experimental Therapeutics
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC547281/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15673752/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.49.2.685-689.2005
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!